These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 477989)

  • 21. Prostaglandin D2, a potential antineoplastic agent.
    Fukushima M; Kato T; Ueda R; Ota K; Narumiya S; Hayaishi O
    Biochem Biophys Res Commun; 1982 Apr; 105(3):956-64. PubMed ID: 6953969
    [No Abstract]   [Full Text] [Related]  

  • 22. Preferential inhibition by 5-bromodeoxyuridine of the synthesis of tyrosine aminotransferase in hepatoma cell cultures.
    Stellwagen RH; Tomkins GM
    J Mol Biol; 1971 Feb; 56(1):167-82. PubMed ID: 4396794
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of glycyl-histidyl-lysine on Morris hepatoma 7777 cells.
    Barra R
    Cytobios; 1987; 52(209):99-107. PubMed ID: 3319436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of 5-bromodeoxyuridine on tumorigenicity, immunogenicity, virus production, plasminogen activator, and melanogenesis of mouse melanoma cells.
    Silagi S
    Int Rev Cytol; 1976; 45():65-111. PubMed ID: 821894
    [No Abstract]   [Full Text] [Related]  

  • 25. Alterations in cellular morphology, proliferative rate and peptide composition accompany dimethylsulfoxide-enhanced liver protein synthesis by hepatoma cells.
    Higgins PJ
    Cell Mol Biol; 1982; 28(3):299-305. PubMed ID: 7116368
    [No Abstract]   [Full Text] [Related]  

  • 26. Insulin receptor levels and magnitude of insulin-induced responses in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
    Shafie SM; Hilf R
    Cancer Res; 1981 Mar; 41(3):826-9. PubMed ID: 6780189
    [No Abstract]   [Full Text] [Related]  

  • 27. Incorporation of 5-fluorouracil into hepatoma and normal tissue RNA at protein depletion in the rat.
    Roos G; Stenram U
    J Surg Oncol; 1997 Jul; 65(3):155-8. PubMed ID: 9236922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunosuppression by ochratoxin A and its prevention by phenylalanine.
    Haubeck HD; Lorkowski G; Kölsch E; Röschenthaler R
    Appl Environ Microbiol; 1981 Apr; 41(4):1040-2. PubMed ID: 7235701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biosynthesis of proteins, nucleic acids and glycosphingolipids by synchronized KB cells.
    Chatterjee S; Sweeley CC; Velicer LF
    Biochem Biophys Res Commun; 1973 Sep; 54(2):585-92. PubMed ID: 4756787
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of phenylalanine amonia-lyase and phenylalanine deprivation on murine leukemic lymphoblasts in vitro.
    Stith WJ; Hodgins DS; Abell CW
    Cancer Res; 1973 May; 33(5):966-71. PubMed ID: 4735727
    [No Abstract]   [Full Text] [Related]  

  • 31. Divergent action of cAMP and dibutyryl cAMP on macromolecular synthesis in HeLa S3 cultures.
    Kaukel E; Fuhrmann U; Hilz H
    Biochem Biophys Res Commun; 1972 Sep; 48(6):1516-24. PubMed ID: 4342713
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies of ochratoxin A-induced inhibition of phenylalanine hydroxylase and its reversal by phenylalanine.
    Zanic-Grubisić T; Zrinski R; Cepelak I; Petrik J; Radić B; Pepeljnjak S
    Toxicol Appl Pharmacol; 2000 Sep; 167(2):132-9. PubMed ID: 10964764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reversible inhibition of ribosomal RNA synthesis in HeLa by lucanthone (Miracil D) with continued synthesis of DNA-like RNA.
    Bases R; Mendez F
    J Cell Physiol; 1969 Dec; 74(3):283-94. PubMed ID: 5358260
    [No Abstract]   [Full Text] [Related]  

  • 34. [Mechanism of action of ochratoxin A, probable agent of endemic Balkan nephropathy].
    Dirheimer G; Röschenthaler R; Creppy E
    Bull Acad Natl Med; 1983 Jan; 167(1):67-74. PubMed ID: 6196096
    [No Abstract]   [Full Text] [Related]  

  • 35. Biological and biochemical effects of chartreusin on mammalian cells.
    Li LH; Clark TD; Murch LL; Wooden JM; Pschigoda LM; Krueger WC
    Cancer Res; 1978 Sep; 38(9):3012-8. PubMed ID: 567097
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of nicotinamide and structural analogs on DNA synthesis and cellular replication of rat hepatoma cells.
    Lea MA; Barra R; Randolph V; Kuhr WG
    Cancer Biochem Biophys; 1984 Sep; 7(3):195-202. PubMed ID: 6237718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ascites hepatoma: a model system to investigate cell protein degradation in the animal as well as in vitro.
    Baccino FM; Tessitore L; Bonelli G; Rubano R; Terzuolo S
    Prog Clin Biol Res; 1985; 180():595-7. PubMed ID: 4034562
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of messenger RNA accumulation but not translation in ultraviolet irradiated hepatoma cells.
    Bushnell DE; Yager JD; Becker JE; Potter VR
    Biochem Biophys Res Commun; 1974 Apr; 57(3):949-56. PubMed ID: 4151268
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparative study of the disposition of (-)-delta 9-tetrahydrocannabinol in neuroblastoma and glioma cells in tissue culture: relation cellular impairment.
    End DW; Thoursen K; Dewey WL; Carchman RA
    Mol Pharmacol; 1977 Sep; 13(5):864-71. PubMed ID: 895721
    [No Abstract]   [Full Text] [Related]  

  • 40. Patulin-induced inhibition of protein synthesis in hepatoma tissue culture.
    Arafat W; Musa MN
    Res Commun Mol Pathol Pharmacol; 1995 Feb; 87(2):177-86. PubMed ID: 7749655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.